Lake Superior QIN invites you to the final part of the National Nursing Home Quality Care Collaborative's Learning Session 5: This sharing call is designed to give nursing home teams an opportunity to collaborate with colleagues regarding successes and barriers related to the reduction of antipsychotic medications. In addition to hearing from other nursing home teams, Lake Superior QIN experts and Dr. Jane Pederson will be available on the call to help nursing homes overcome barriers they may be having. To get the most out of this collaborative opportunity, come prepared to share successful strategies you have implemented and/or barriers you are encountering in your work to reduce the use of these medications.
Hear successful strategies from a consultant pharmacist on identifying, reporting and treating dementia behavioral expressions in long-term care residents. Learn non-pharmacological interventions that can address a resident’s dementia while reducing overall antipsychotic medication use. This learning session is part of the National Nursing Home Quality Care Collaborative's Learning Session 5.
Lake Superior QIN invites you to the second webinar of Learning Session 5: The demographics of long-term care populations are changing: increasingly more younger adults are in need of long-term care. This webinar will cover strategies to identify and address the mental health complexities in this younger long-term care population in order to improve their overall quality of life.
The National Nursing Home Quality Care Collaborative invites you to the first webinar of Learning Session 5. Dementia care is the topic of this webinar, with special emphasis on reducing unnecessary antipsychotic medications and how QAPI can help homes achieve this reduction.
During this call, learn how to work with physicians to ensure compliance with the new psychotropic medication prescribing requirements for long-term care facilities. Also, find out how nursing homes are putting the new Quality Assurance Performance Improvement (QAPI) requirements into practice. Additionally, CMS experts share updates on the progress of the National Partnership to Improve Dementia Care in Nursing Homes and QAPI. A question and answer session follows the presentations.
[caption id="attachment_7376" align="alignright" width="150"] Kelly O'Neill, RN, BSN, MPA, CPHQ[/caption]
[caption id="attachment_5407" align="alignright" width="136"] Sue Ann Guildermann[/caption]
An opportunity for nursing homes participating in the NNQCC to share barriers and successes they have had in reducing the use of antipsychotic medication in residents with dementia.
The Reform of Requirements for Long-Term Care states that long-term care facilities must assure that a resident who displays or is diagnosed with dementia receives the appropriate treatment and services to attain or maintain his or her highest practicable physical, mental, and psychosocial well-being. The use of psychotropic medications in residents with dementia does not always contribute to the highest potential of the residents. In this webinar, Dr. Sonntag will identify when it is appropriate to use these medications. In addition he will review the importance of specifying and monitoring the target behavior for which a medication or non-pharmacologic intervention is being used, as well as ideas on how to engage your medical director, physicians, and/or nurse practitioners in your efforts to reduce the inappropriate use of these medications.